Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
Hfq4KWFbyJ3ueawk